Chemoinformaics analysis of 9,12-Octadecadienoic acid (Z,Z)
| Molecular Weight | 562.92 | nRot | 29 |
| Heavy Atom Molecular Weight | 496.392 | nRig | 2 |
| Exact Molecular Weight | 562.496 | nRing | 0 |
| Solubility: LogS | -5.559 | nHRing | 0 |
| Solubility: LogP | 7.131 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 106 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 66 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 107.336 |
| nHD | 2 | BPOL | 67.9477 |
| QED | 0.291 |
| Synth | 2.033 |
| Natural Product Likeliness | 0.869 |
| NR-PPAR-gamma | 0.983 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.922 |
| MDCK | 0.0000232 |
| BBB | 0.101 |
| PPB | 0.987626 |
| VDSS | 0.74 |
| FU | 0.0123849 |
| CYP1A2-inh | 0.32 |
| CYP1A2-sub | 0.183 |
| CYP2c19-inh | 0.184 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.256 |
| CYP2c9-sub | 0.99 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.067 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.016 |
| CL | 2.573 |
| T12 | 0.546 |
| hERG | 0.038 |
| Ames | 0.004 |
| ROA | 0.016 |
| SkinSen | 0.951 |
| Carcinogencity | 0.084 |
| EI | 0.97 |
| Respiratory | 0.704 |
| NR-Aromatase | 0.149 |
| Antiviral | No |
| Prediction | 0.581705 |